Aeterna Zentaris
AEZS
#10804
Rank
HK$0.13 B
Marketcap
HK$44.85
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2023 (TTM): -HK$36.48

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is -HK$16.07. In 2022 the company made an earnings per share (EPS) of -HK$36.62 a decrease over its 2021 EPS that were of -HK$15.37.

EPS history for Aeterna Zentaris from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$36.48-0.38%
2022-HK$36.62138.27%
2021-HK$15.37-48.05%
2020-HK$29.58-56.88%
2019-HK$68.61-240%
2018HK$49.01-122.94%
2017-HK$213.68-54.96%
2016-HK$474.40-93.07%
2015-HK$6,84320.13%
2014-HK$5,697-225.69%
2013HK$4,532-122.24%
2012-HK$20,384-42.55%
2011-HK$35,482-12.98%
2010-HK$40,775-17.46%
2009-HK$49,401-62.5%
2008-HK$131,73583.66%
2007-HK$71,728-227.16%
2006HK$56,409105.81%
2005HK$27,408-334.56%
2004-HK$11,685-79.94%
2003-HK$58,25813.5%
2002-HK$51,330604.55%
2001-HK$7,285-84.33%
2000-HK$46,504275.3%
1999-HK$12,391

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
HK$41.17-356.23%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
HK$14.92-192.88%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
HK$35.44-320.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-HK$2.82-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
HK$27.60-271.80%๐Ÿ‡บ๐Ÿ‡ธ USA